Beta Bionics (BBNX) Stock Price, News & Analysis

BBNX Stock Analysis - Frequently Asked Questions

How have BBNX shares performed this year?

Beta Bionics' stock was trading at $23.81 at the beginning of the year. Since then, BBNX stock has decreased by 19.1% and is now trading at $19.27.
View the best growth stocks for 2025 here.

How were Beta Bionics' earnings last quarter?

Beta Bionics, Inc. (NASDAQ:BBNX) announced its quarterly earnings data on Tuesday, May, 6th. The company reported ($0.52) EPS for the quarter, missing the consensus estimate of ($0.51) by $0.01.
Read the conference call transcript.

When did Beta Bionics IPO?

Beta Bionics (BBNX) raised $204 million in an IPO on Thursday, January 30th 2025. The company issued 12,000,000 shares at a price of $17.00 per share.

When does the company's lock-up period expire?

Beta Bionics' lock-up period expires on Tuesday, July 29th. Beta Bionics had issued 12,000,000 shares in its initial public offering on January 30th. The total size of the offering was $204,000,000 based on an initial share price of $17.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Who are Beta Bionics' major shareholders?

Top institutional shareholders of Beta Bionics include Eventide Asset Management LLC (11.37%), Wellington Management Group LLP (9.00%), Sands Capital Ventures LLC (7.16%) and Omega Fund Management LLC (4.59%). Insiders that own company stock include Hadley Harbor Aggre Wellington, Mike Mensinger, Steven Jon Russell, Stephen Feider and Mark Hopman.
View institutional ownership trends.

How do I buy shares of Beta Bionics?

Shares of BBNX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.